Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4⁺ T lymphocytes - 04/02/21

Doi : 10.1016/j.jaci.2020.05.041

Jobst F. Roehmel, MD ^a,^{^{∗
These authors contributed equally to this work.}}, Monday O. Ogese, PhD ^b,^{^{∗
These authors contributed equally to this work.}}, Alexander Rohrbach, MSc ^a, Marcus A. Mall, MD ^a,^c,^d,^{^{‡
These authors contributed equally as senior authors.}}, Dean J. Naisbitt, PhD ^b,^{^{‡
These authors contributed equally as senior authors.}}
^a Department of Pediatric Pulmonology, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany
^b Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom
^c Berlin Institute of Health (BIH), Berlin, Germany
^d German Center for Lung Research (DZL), Berlin, Germany

This study was funded in part by a grant from the German Cystic Fibrosis Association Mukoviszidose e.V. (grant no. 1705). M.O. is a postdoctoral researcher funded by the Biotechnology and Biological Sciences Research Council (BBSRC, grant no. BB/R008108/1). M.A.M. has been supported by grants from the German Federal Ministry of Education and Research (grant no. 82DZL004A1) and the Einstein Foundation Berlin (grant no. EP-2017-393).

Disclosure of potential conflict of interest: The authors declare that they have no relevant conflict of interest.

Export

Vol 147 - N° 2

P. 753-756 - février 2021 Retour au numéro

Article précédent

Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency
Leslie Naesens, Julie Smet, Simon J. Tavernier, Petra Schelstraete, Levi Hoste, Stijn Lambrecht, Helene Verhelst, Jutte van der Werff ten Bosch, Alina Ferster, Sophie Blumental, Pascale Hilbert, Tessa Kerre, Johan Vande Walle, Christoph Licht, Lubka T. Roumenina, Patrick Stordeur, Filomeen Haerynck

| Article suivant

T_H cell diversity and response to dupilumab in patients with atopic dermatitis
Coline Trichot, Lilith Faucheux, Léa Karpf, Maximilien Grandclaudon, Lucia Pattarini, Martine Bagot, Thibault Mahévas, Marie Jachiet, Anne Saussine, Jean-David Bouaziz, Vassili Soumelis

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4⁺ T lymphocytes - 04/02/21

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL